Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
English speaking
Physician diagnosis of early-stage Alzheimer's disease or mild cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up will be administered at week 0 (prior to first therapy session) to establish a baseline. measures at week 8 (midpoint of therapy sessions), and week 16 (following last therapy session) will determine change from the baseline.
Awards & highlights
Study Summary
This trial will use 3D printing to create personalized objects for people with dementia, in order to improve their mood, quality of life, social interaction, and cognition.
Eligible Conditions
- Dementia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ will be administered at week 0 (prior to first therapy session) to establish a baseline. measures at week 8 (midpoint of therapy sessions), and week 16 (following last therapy session) will determine change from the baseline.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~will be administered at week 0 (prior to first therapy session) to establish a baseline. measures at week 8 (midpoint of therapy sessions), and week 16 (following last therapy session) will determine change from the baseline.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Cognitive stimulation/reminiscence
Secondary outcome measures
Dementia
Change in Dementia severity-SLUMS
Change in Dementia severity-dependence on assistance
+3 moreOther outcome measures
Functionality and usability of 3D printing mobile tools and paradigm for RT
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: 8 Weeks of 3D-RTExperimental Treatment1 Intervention
Participants will receive 8weeks of Reminiscence Therapy using 3D printed objects as stimuli and 8 weeks of RT using verbal stimuli.
Group II: 16 Weeks of 3D-RTExperimental Treatment1 Intervention
Participants will receive 16 weeks of Reminiscence Therapy using 3D printed objects as stimuli.
Group III: 16 Weeks of RT using Verbal StimuliActive Control1 Intervention
Participants will receive 16 weeks of RT using verbal stimuli to reminiscence.
Find a Location
Who is running the clinical trial?
The University of Texas at ArlingtonOTHER
40 Previous Clinical Trials
4,638 Total Patients Enrolled
2 Trials studying Dementia
533 Patients Enrolled for Dementia
Moai Technologies LLCLead Sponsor
1 Previous Clinical Trials
96 Total Patients Enrolled
University of Texas-ArlingtonUNKNOWN
4 Previous Clinical Trials
600 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger